Below you'll find a list of all posts that have been categorized as “Cannabis Treatments”
Dr. Jeff Chen is the Co-founder and CEO of Radicle Science, a health tech company generating history’s first dataset and AI to prove and predict the effects of health and wellness products. Previously, he was the Founder and Exec Director of the UCLA Cannabis Research Initiative. At CannMed 2022, Dr. Chen presented results for Radicle Health’s ACES study, a randomized …
CannMed 2022 is officially in the books. Thank you to all our attendees, presenters, sponsors, exhibitors, media partners, and team members behind the scenes who make it all possible. It was great to see everyone in person again and learn about the latest advancements in the field. We discussed novel cannabinoids, new treatment protocols, exciting new advances in breeding and cultivation, …
Dr. Kevin Spelman returns to discuss what research has been done on the minor cannabinoids. The major cannabinoids, Delta-9 THC and CBD, have gotten most of the attention when it comes to cannabis medicine research. But we know that cannabis medicine is a team effort, and there are a variety of compounds that contribute to the entourage effect, including terpenoids, flavonoids, …
Jaime Brambila and his wife Nicole specialize in coaching and educating patients about the clinical use of cannabinoids and other plant-based medicines. The principal aspects of their mission are to democratize plant-based medicine and democratize the science, taking the complex pharmacological information and breaking it down so everyone can understand the therapeutic potential. At CannMed 2022, Jaime will present a …
Itzhak Kurek, PhD is CEO & Co-Founder of Cannformatics. Itzhak and his team are measuring the effectiveness of cannabis-based medicines using biomarkers. So far, they have identified dozens of cannabis-responsive biomarkers that can be used to objectively quantify the physiological impact of medical cannabis treatment and provide a tool for investigating the metabolic pathways affected by medical cannabis and CBD. …
Dr. Ethan Russo returns to the podcast to help us make sense of the slew of studies and articles claiming cannabis can treat and/or prevent COVID-19 infection. Dr. Russo is a board-certified neurologist, a psychopharmacology researcher, an author, a lecturer, and a consultant. He is a CannMed 2022 Keynote Presenter, where he will present on Cannabis and Psychiatry. Although Dr. …
Dr. Bonni Goldstein returns to the podcast to discuss examples where cannabis may be a safer and more effective therapeutic than traditional pharmaceutical drugs. Bonni is one of the country’s most respected and experienced medical cannabis physicians, having treated thousands of patients with medical cannabis. She is the owner and medical director of Canna-Centers Wellness & Education. She is Clinical …
Dedi Meiri, PhD runs a lab at the Technion Israel Institute of Technology that investigates the anti-tumor effects of cannabinoids. More specifically, his team identifies which combination of cannabinoids can kill cancer cells. Most notably, his team identified three specific cannabinoids that kill leukemia cells and that formulation is currently being tested in a clinical trial in Israel. Dr. Meiri …
Michael Levinsohn is a criminal and civil defense attorney with 20 years of experience representing people in all areas of the cannabis industry, including patients, cultivators, retailers, and healthcare providers. We catch up on new developments in cannabis law since last we spoke, including Ryan’s Law, which requires California hospitals providing palliative care allow terminally ill patients to use cannabis …
John Malanca co-founded United Patients Group (UPG), a trusted resource and leader in medical cannabis information and education for patients, physicians, pharmacists, governments, and organizations, both domestically and internationally. UPG also acts as a virtual hand for patients and their loved ones struggling with chronic and terminal illnesses by helping them navigate through this ever-changing industry. At CannMed 2021, John …
